18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study.

Purpose: This study evaluated the ability of 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorothymidine (FLT) imaging with positron emission tomography (PET) to measure early response to endocrine therapy from baseline to just prior to surgical resection in estrogen receptor positive (ER+) breast tumors.M...

Descripción completa

Detalles Bibliográficos

Publicado en:	Breast Cancer Research Vol. 23; no. 1; pp. 1 - 12
Autores principales:	Romine, Perrin E., Peterson, Lanell M., Kurland, Brenda F., Byrd, Darrin W., Novakova-Jiresova, Alena, Muzi, Mark, Specht, Jennifer M., Doot, Robert K., Link, Jeanne M., Krohn, Kenneth A., Kinahan, Paul E., Mankoff, David A., Linden, Hannah M.
Formato:	research Journal Article
Publicado:	BioMed Central 8/23/2021
Acceso en línea:	Ver este registro en EBSCOhost